Micron Technology Inc (MU) Report Interpretation

Overview

UBS's management-meeting update argues that investor concern over Micron's strategic customer agreements, gross-margin peak and future capacity additions overlooks increasingly tight memory supply, improving HBM economics and broader revenue visibility. UBS maintains Buy and a US$1,625 price target.

Core views

UBS says meetings with investors were dominated by downside concerns: whether strategic customer agreements (SCAs) will hold up, whether gross margin is peaking, whether supply tightness can persist, and how much new capacity will arrive. The firm sees investor positioning as cautious and believes this creates an opportunity if Micron's earnings prove more durable than feared. UBS expects the stock to remain a near-term battleground because margins may peak as more volume shifts into SCAs priced one to two quarters earlier. Its longer-term thesis is that memory captures a more sustained share of AI token-generation economics, with memory revenue becoming more important relative to compute. Management's demand commentary strengthened the supply thesis. Micron now characterizes calendar 2027 supply-demand conditions as tighter than calendar 2026, and it is still fulfilling less than 50% of data-center customer volume requests. On high-bandwidth memory, management intends to raise HBM gross margins because of the product's higher value and because existing contracts were signed before DDR price increases. UBS says this is consistent with its forecast for blended industry HBM ASPs to rise 79% year on year in 2027. Management also reiterated that mid-US$40 billion remains a valid FY2027 capex estimate. UBS highlights more revenue visibility than headline backlog metrics suggest. Micron expects more than 50% of revenue to be covered by SCAs. About 10% of total revenue is expected to be under take-or-pay arrangements without fixed or pre-contracted pricing; within the remaining 40%, some contracts have fixed pricing and others use ceiling-and-floor price bands. UBS also sees long-term visibility for bits sold outside SCAs through agreements that may not specify price but support capacity planning. Reported remaining performance obligations understate this visibility because they exclude the roughly 10% of take-or-pay revenue and customer allocations beyond about 12 months. On supply, UBS notes that the largest incremental DRAM capacity for 2027 should be Micron's ID1 facility at roughly 80,000 wafers per month and Tongluo brownfield capacity at roughly 40,000 wafers per month, both expected online in mid-2027. Singapore HBM back-end packaging should also begin ramping in 2027. More meaningful net additions are expected in 2028, including Tongluo greenfield capacity of roughly 40,000 wafers per month, ID2 at roughly 80,000 wafers per month, and an expansion of Hiroshima Fab 15. This timing supports the firm's view that tight conditions can persist before supply additions become more substantial. Capital allocation remains secondary to business investment, particularly geographic diversification. UBS projects Micron will have about US$75 billion of cash by the end of fiscal Q1 2027, before the 9 December expiry of CHIPS Act-related share-repurchase limits. UBS believes Micron will ultimately repurchase a very large amount of stock, but management's emphasis on doing so gradually and over time leads it to caution against expecting a near-term announcement. UBS made no model changes and maintained its US$1,625 target. The valuation applies an approximately 11x NTM P/E multiple, in line with Micron's three-year historical average, to its calendar-2029 EPS estimate of about US$165. That estimate is discounted back to 2028E at an approximately 12% cost of equity, producing an implied 2028E EPS value of about US$148. UBS anchors on 2029 because it views that year as a better representation of through-cycle earnings power under long-term agreements, even though its model assumes a moderate memory downcycle by then.

Analysis framework

UBS combines management-meeting observations with supply-demand analysis, contract-structure detail, capacity timing and earnings forecasts. It then values Micron using a forward P/E multiple applied to calendar-2029 EPS and discounted back to 2028E.

Methodology notes

• Industry AnalysisSupply-demand framework

  Memory supply-demand analysis

  UBS assesses customer demand, unmet data-center volume requests, capacity additions and their timing to judge the durability of memory-market tightness and pricing.

• Valuation methodsP/E and PEG Valuation

  Forward P/E valuation

  UBS applies an approximately 11x next-twelve-month P/E multiple to its calendar-2029 EPS estimate and discounts the resulting value back using an approximately 12% cost of equity.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Micron Technology Inc (MU.O)

  Primary covered company; UBS sees durable memory earnings and tight supply-demand conditions as supportive.

  Strengths

  Less than 50% fulfillment of requested data-center volumes, expected tighter 2027 conditions, rising HBM economics and greater revenue visibility through SCAs and related agreements.

  Weaknesses

  Gross margins may peak as more volume moves into SCAs priced one to two quarters earlier.

  Comparison

  UBS's approximately 11x NTM P/E target multiple is in line with Micron's three-year historical average.

  Risks

  Worsening macro conditions, sharper-than-expected ASP declines, technology-migration delays and potential supply additions.

Key data

• 12-month price targetUS$1,625Unchanged; based on approximately 11x NTM P/E.
• Share priceUS$1,011.75As of 17 Aug 2026.
• Forecast stock return60.7%Comprises 60.6% forecast price appreciation and 0.1% forecast dividend yield.
• Data-center requested volumes fulfilledLess than 50%Management indication cited by UBS.
• 2027 blended HBM ASP forecast+79% year on yearUBS industry forecast.
• FY2027 capex estimateMid-US$40 billionManagement reiterated this estimate.
• Calendar-2029 EPS estimateApproximately US$165Used in UBS's target-price valuation.
• Implied 2028E EPS valueApproximately US$148Derived after discounting calendar-2029 EPS at an approximately 12% cost of equity.

Impact & implications

UBS believes tighter supply, HBM price and margin improvement, and contract-supported revenue visibility can make Micron's earnings base more durable than investors expect. It also expects nearer-term gross-margin concerns and the pace of buybacks to remain areas of debate.

Risks

• Memory demand could weaken if global economic conditions deteriorate, leading to demand destruction.
• ASP declines could be more severe than UBS expects as incremental supply is added.
• DRAM and NAND technology scaling is complex, and slower-than-expected technology migration could pressure the stock.
• The report notes that future supply additions could weigh on ASPs; conversely, delayed additions could create upside bias.